A novel combination treatment against melanoma with <scp>NRAS</scp> mutation and therapy resistance
Crossref DOI link: https://doi.org/10.15252/emmm.201708573
Published Online: 2018-04-16
Published Print: 2018-05
Update policy: https://doi.org/10.1002/crossmark_policy
Yu, Yanlin https://orcid.org/0000-0003-1513-3343
Funding for this research was provided by:
National Institutes of Health
Version of Record valid from 2018-04-16
Publication History
Published: 2018-04-16